Kerala, WB Used ‘Extra Dose’, Reported Negative Vax Wastage

New Delhi : Exemplary performance by Kerala and West Bengal which recorded a negative (-6.3% and -5.4%) vaccine wastage, saving 1.1 lakh and 1.6 lakh doses respectively, shows that optimum use and diligent supply management of vaccines is possible, said central government officials.

In fact, the two states reported negative wastage of Covid vaccines by making use of the “extra dose” available as a wastage factor in each vial.

Official data for May show Kerala and West Bengal standing in sharp contrast to states like Jharkhand and Chhattisgarh which recorded a high 33.9% and 15.7% wastage respectively. The wastage for other states is lower, but still on the higher side like in Madhya Pradesh (7.3%) and Punjab (7%). Doing better, but still short of the optimum 1% suggested by the Centre are Delhi (3.9%), Gujarat (3.6%), Rajasthan (3.9%) and UP (3.7%).

Government sources said the closing balance of shots with various states was 212 lakh. The month saw a poor rate of vaccination due to a switch to a new procurement system — since abandoned — and a fear of infection that kept people indoors. The closing balance of vaccines was less at 80 lakh in April. However, it was higher in February and March, with the latter marked by a misplaced sense of complacency that the infection had ebbed. This had resulted in vaccination slots going unutilised.

The first dose coverage of the 45-plus population stands at 38%, with Tamil Nadu, Jharkhand, Bihar and Assam lagging at sub- 30% levels. Better performing states include Rajasthan, Chhattisgarh, Gujarat and Karnataka.

Second dose coverage among front-line workers stands at 45%, with Rajasthan, Chhattisgarh, Bengal, Kerala and MP being the better performing states. First dose coverage is at 84%. Worryingly, second dose coverage for healthcare workers is only 56% while for first dose it is 81%.

  • Related Posts

    • Pharma
    • July 22, 2025
    • 144 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    • Pharma
    • July 16, 2025
    • 569 views
    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug